Title: Efficacy of transcatheter arterial embolization in treating nonvariceal gastric remnant
bleeding: a retrospective 5-year study
Version: 0 Date: 05 Jan 2024
Reviewer's report:
1. Transarterial embolization is a recognizable therapeutic option for control of UGI bleeding.
This article focused on populations of UGI bleeding originating from remnant stomach that
scarcely found in the literature and therefore deserved appreciation.
2. There are some points that the authors should describe clearly before consideration of
acceptance for publication.
(1). It is usually estimated that cancer might develop from remnant stomach averagely 15 years
postoperatively. How long the duration between the occurrence of UGI bleeding and operation
for the stomach including for both benign and malignant diseases in these patients?
(2) Massive bleeding usually occurred from a relatively larger artery. What the endoscopic
appearance of gastritis or erosion that may account for this kind of severe condition?
(3) In the inclusion criteria (3) and (4), patients cannot tolerate endoscopic treatment and patient
underwent at least one failed endoscopic treatment are included, these two points seemed to
have conflict.
(4) In the background section, line 65, please showed the reference to explain the reason why
“low acid gastric acid levels increase gastrointestinal reflux…”.
(5) For patients without evidence of contrast media extravasation and empirical embolization
was performed, how broad the blood supply territories are included and what kind of agents will
have the priority to be selected?
Title: Efficacy of transcatheter arterial embolization in treating nonvariceal gastric remnant
bleeding: a retrospective 5-year study
Version: 0 Date: 05 Jan 2024
Reviewer's report:
1. Transarterial embolization is a recognizable therapeutic option for control of UGI bleeding.
This article focused on populations of UGI bleeding originating from remnant stomach that
scarcely found in the literature and therefore deserved appreciation.
2. There are some points that the authors should describe clearly before consideration of
acceptance for publication.
(1). It is usually estimated that cancer might develop from remnant stomach averagely 15 years
postoperatively. How long the duration between the occurrence of UGI bleeding and operation
for the stomach including for both benign and malignant diseases in these patients?
(2) Massive bleeding usually occurred from a relatively larger artery. What the endoscopic
appearance of gastritis or erosion that may account for this kind of severe condition?
(3) In the inclusion criteria (3) and (4), patients cannot tolerate endoscopic treatment and patient
underwent at least one failed endoscopic treatment are included, these two points seemed to
have conflict.
(4) In the background section, line 65, please showed the reference to explain the reason why
“low acid gastric acid levels increase gastrointestinal reflux…”.
(5) For patients without evidence of contrast media extravasation and empirical embolization
was performed, how broad the blood supply territories are included and what kind of agents will
have the priority to be selected?
Please review this paper.
user
Title: Efficacy of transcatheter arterial embolization in treating nonvariceal gastric remnant
bleeding: a retrospective 5-year study
Version: 0 Date: 05 Jan 2024
Reviewer's report:
1. Transarterial embolization is a recognizable therapeutic option for control of UGI bleeding.
This article focused on populations of UGI bleeding originating from remnant stomach that
scarcely found in the literature and therefore deserved appreciation.
2. There are some points that the authors should describe clearly before consideration of
acceptance for publication.
(1). It is usually estimated that cancer might develop from remnant stomach averagely 15 years
postoperatively. How long the duration between the occurrence of UGI bleeding and operation
for the stomach including for both benign and malignant diseases in these patients?
(2) Massive bleeding usually occurred from a relatively larger artery. What the endoscopic
appearance of gastritis or erosion that may account for this kind of severe condition?
(3) In the inclusion criteria (3) and (4), patients cannot tolerate endoscopic treatment and patient
underwent at least one failed endoscopic treatment are included, these two points seemed to
have conflict.
(4) In the background section, line 65, please showed the reference to explain the reason why
“low acid gastric acid levels increase gastrointestinal reflux…”.
(5) For patients without evidence of contrast media extravasation and empirical embolization
was performed, how broad the blood supply territories are included and what kind of agents will
have the priority to be selected?
assistant